LIPOSOMAL BUPIVACAINE
Clinical trials for LIPOSOMAL BUPIVACAINE explained in plain language.
Never miss a new study
Get alerted when new LIPOSOMAL BUPIVACAINE trials appear
Sign up with your email to follow new studies for LIPOSOMAL BUPIVACAINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New 3-Day numbing shot could cut opioid use after surgery
Symptom relief Recruiting nowThis study is testing a new, long-acting numbing medicine for pain relief after common keyhole abdominal surgeries like gallbladder removal. Researchers want to see if a single injection of this slow-release medicine, given during surgery, can provide better and longer pain contr…
Matched conditions: LIPOSOMAL BUPIVACAINE
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Apr 02, 2026 14:56 UTC
-
Could a single shot ease days of surgery pain?
Symptom relief Recruiting nowThis study is testing a new, long-acting numbing medicine to see if it works better than the standard one at reducing pain after common keyhole surgeries like gallbladder removal. Researchers will compare pain levels and the need for extra painkillers in about 190 adults. The goa…
Matched conditions: LIPOSOMAL BUPIVACAINE
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC
-
New shot aims to block pain for days after lung surgery
Symptom relief Recruiting nowThis study is testing if a new, long-acting numbing medicine (liposomal bupivacaine) works better than the standard numbing medicine when injected into the surgical cuts after minimally invasive lung surgery. Researchers want to see if it reduces pain and the need for strong pain…
Matched conditions: LIPOSOMAL BUPIVACAINE
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Mar 30, 2026 14:34 UTC
-
New Long-Lasting pain shot could reduce need for opioids after surgery
Symptom relief Recruiting nowThis study is testing whether a new, long-lasting numbing medicine (liposomal bupivacaine) works better than a standard one (ropivacaine) at reducing pain after major abdominal surgery. Doctors will inject one of these medicines into the surgical area right before closing the inc…
Matched conditions: LIPOSOMAL BUPIVACAINE
Phase: NA • Sponsor: Qilu Hospital of Shandong University • Aim: Symptom relief
Last updated Mar 24, 2026 12:02 UTC
-
New injection aims to block pain for days after cancer surgery
Symptom relief Recruiting nowThis study is testing a new, long-acting numbing medicine for pain relief after minimally invasive surgery for gynecologic cancers. Researchers want to see if an injection near the abdominal wall can provide better, longer-lasting pain control than standard options, which could h…
Matched conditions: LIPOSOMAL BUPIVACAINE
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Mar 24, 2026 12:01 UTC
-
New 3-Day pain relief shot tested for chest surgery patients
Symptom relief Recruiting nowThis study is testing a new, long-acting pain relief injection for patients having a type of minimally invasive chest surgery. Researchers want to see if a special nerve block using a slow-release numbing medicine can better control pain after surgery compared to standard methods…
Matched conditions: LIPOSOMAL BUPIVACAINE
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Mar 23, 2026 15:18 UTC
-
New Long-Lasting pain shot tested for knee surgery recovery
Symptom relief Recruiting nowThis study aims to find the best dose of a long-acting numbing medicine (liposomal bupivacaine) given as a nerve block to control pain after knee replacement surgery. Researchers will compare how well different doses reduce pain and the need for opioid painkillers in 177 adults u…
Matched conditions: LIPOSOMAL BUPIVACAINE
Phase: PHASE3 • Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Mar 17, 2026 13:09 UTC